Trial NCT03168438

View at ClinicalTrials.gov 
Org. Study IDs: 208470
Secondary IDs: ADP-0011-008 KEYNOTE-487

Last trial update was posted on 2022-01-11

MeSH Interventions

Cyclophosphamide Fludarabine Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Neoplasms

Stopping Reasons

The study was terminated following an internal review of the company's research and development portfolio

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID